MENU
+Compare
RVMD
Stock ticker: NASDAQ
AS OF
Mar 14 closing price
Price
$39.12
Change
+$0.09 (+0.23%)
Capitalization
7.27B

RVMD Revolution Medicines Forecast, Technical & Fundamental Analysis

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways... Show more

RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RVMD with price predictions
Mar 14, 2025

RVMD's Indicator enters downward trend

The Aroon Indicator for RVMD entered a downward trend on March 14, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 186 similar instances where the Aroon Indicator formed such a pattern. In of the 186 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RVMD as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where RVMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RVMD just turned positive on March 14, 2025. Looking at past instances where RVMD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RVMD advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

RVMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RVMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.209) is normal, around the industry mean (11.661). P/E Ratio (0.000) is within average values for comparable stocks, (63.786). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.805). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. RVMD's P/S Ratio (10000.000) is very high in comparison to the industry average of (239.652).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVMD is expected to report earnings to fall 3.57% to -108 cents per share on May 12

Revolution Medicines RVMD Stock Earnings Reports
Q1'25
Est.
$-1.08
Q4'24
Missed
by $0.13
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.05
The last earnings report on February 26 showed earnings per share of -112 cents, missing the estimate of -99 cents. With 810.43K shares outstanding, the current market capitalization sits at 7.27B.
A.I. Advisor
published General Information

General Information

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GUSH24.951.61
+6.90%
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF
XMLV61.141.08
+1.80%
Invesco S&P MidCap Low Volatility ETF
RSBT16.820.05
+0.30%
Return Stacked Bonds & Managed Futs ETF
VMOT26.25N/A
N/A
EA Series Trust Alpha Architect Value Momentum Trend ETF
DFCF41.91-0.06
-0.14%
Dimensional Core Fixed Income ETF

RVMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with IDYA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.18%
IDYA - RVMD
45%
Loosely correlated
-1.90%
ERAS - RVMD
45%
Loosely correlated
-2.04%
RYTM - RVMD
43%
Loosely correlated
+1.45%
KYMR - RVMD
43%
Loosely correlated
+2.75%
DYN - RVMD
42%
Loosely correlated
+1.52%
More